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ABSTRACT
Background: Periodontitis is a chronic inflammatory condition believed to cause a low but long lasting systemic 
inflammatory reaction which in turn contributes to the development of atherosclerosis. Recent data suggests 
that around 40% cases of coronary artery disease remain unaccounted despite the identification of the classical 
risk factors. Objectives: To evaluate the efficacy of non surgical periodontal therapy on the levels of serum 
inflammatory markers in subjects with chronic periodontitis and known coronary artery disease. Materials and 
Methods: Twenty subjects with known coronary artery disease (CAD) were recruited from the Department 
of Cardiology, CSM Medical University, Lucknow, India, for this study. Periodontal disease was measured 
through the clinical parameters bleeding on probing (BOP) and probing depth (PD). All subjects received non 
surgical periodontal therapy that included oral hygiene instructions and meticulous scaling and root planing. 
Systemic levels of inflammatory markers such as high-sensitivity C reactive proteins (hsCRP), tumor necrosis 
factor-α (TNF-α), and white blood cell (WBC) counts were measured prior to and 1 month after periodontal 
therapy. Results: Subjects experienced significant reductions in bleeding on probing (BOP) and probing 
depth (PD), indicating improvement in overall periodontal health. In all subjects, high-sensitivity C reactive 
proteins (hsCRP), and WBC counts were reduced significantly,; however, tumor necrosis factor-α (TNF-α) 
levels showed no statistically significant reduction. Conclusion: In this study, periodontal treatment resulted 
in a significant decrease in bleeding on probing (BOP) and probing depth (PD), and this treatment lowered 
the serum inflammatory markers (hsCRP and WBC counts) in patients with coronary artery disease. This may 
result in a decreased risk for coronary artery disease in the periodontally treated patients.
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form and will be a major cause of death in developing 
countries by the year 2020.[1] Over 29.8 million people have 
coronary artery disease in India.[1] Studies conducted in 
India show that every second person above 35yrs of age 
has periodontal pockets and 30% of total teeth extracted 
after 35yrs of age are due to periodontal disease.[2] As a 
result of high prevalence of both coronary artery disease 
(CAD) and periodontal disease it has led to a hypothesis 
that these might be connected.[3]
Framingham heart study has identified a list of classical 
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risk factors (hypertension, male gender, age, smoking, 
diabetes mellitus, and obesity). However, they were not 
sufficient to account for the etiology of this multifactorial 
pathological process. Although major improvements have 
been made in primary and secondary prevention of major 
risk factors of CAD, it continues to be highly prevalent. 
Around 40% cases of atherosclerosis cannot be attributed 
to the classical risk factors.
Due to these facts, there is an increased interest for 
considering chronic infections as a risk factor for 
atherosclerosis.[4] As inflammatory mechanisms play a 
central role in mediating all phases of atherosclerosis and 
destructive periodontal disease, when left untreated they 
become a chronic inflammatory condition leading to an 
increase in local and systemic inflammatory mediators. 
Thus, perio systemic connection is a major current interest 
in periodontology.
Periodontal associated inflammatory process contributes 
to an increase in inflammatory mediators including tumor 
necrosis factor-α (TNF-α), C reactive proteins (CRP) and 
interleukin- 6 (IL- 6).[5]
Epidemiological studies have associated plasma levels of 
IL-6 and TNF - α with cardio vascular risk factors and have 
associated IL- 6levels with a risk of CAD.
Thus, the purpose of this interventional survey was to see 
the effect of periodontal treatment on levels of serum 
inflammatory markers CRP, TNF-α and white blood cell 
(WBC) counts.
MATERIALS AND METHODS
Twenty subjects were recruited from the Department of 
Cardiology, CSM Medical University, Lucknow, India, for 
the survey. Subjects with a chronic generalized periodontitis 
having coronary artery disease confirmed by clinical 
findings and ECG as interpreted by a cardiologist were 
included in the study.
Exclusion criteria included current smoking, smoking 
within last 6 months, diabetes and acute/chronic systemic 
diseases (e.g. influenza, rheumatoid arthritis, COPD, or 
kidney disease), antibiotics or anti inflammatory drug 
administration within the last 2 months, and pregnancy/
lactation.
Clinical periodontal parameters
Probing depth was recorded at six sites per tooth (mesio 
buccal, mid buccal, disto buccal, mesio lingual, mid lingual, 
and disto lingual).[6] Probing depth was recorded to the 
nearest millimeter using UNC 15 probe.
The presence or absence of bleeding was recorded using 
Sulcular Bleeding Index (SBI, Muhlemann and Son 1971).[7]
All subjects received oral prophylaxis and sublingual 
scaling and root planing. Oral hygiene instructions were 
given and the subjects were recalled 1 month after the last 
treatment visit.
Serum inflammatory markers
Serum high-sensitivity C reactive protein (hsCRP) was 
measured by using particle- enhanced turbidimetric assay 
(hsCRP, latex, COBAS, Integra 400 plus, ROCHE, Basel, 
Switzerland). Precipitate was determined turbidimetrically 
at 552 nm. The lower limit of assay was 0.1mg/ml.
TNF- α serum levels were determined by sensitive enzyme- 
linked immunosorbent assay (ELISA) using commercially 
available kit (R and D systems Inc, Minneapolis, MN, USA). 
The lower limit of detection was 0.06 pg/ml. The plates 
were read using an automated microplate reader (Bio Rad, 
Hercules, California, USA).
WBC count (×/109) was obtained.
All the parameters (PD, BOP, hsCRP, TNF-α, WBC counts) 
were obtained at the baseline and 1 month post treatment.
Statistical analysis
The data collected were analyzed using non parametric 
Wilcoxon signed rank test. P values ≤ 0.05 were considered 
statistically significant.
RESULTS
There was a statistically significant reduction in BOP and 
PD post treatment. BOP was reduced by 28% and PD 
was reduced by 41% at the end of 1 month [Table 1].
hsCRP and WBC levels were significantly reduced post 
treatment. However, the levels of TNF α were not 
significantly reduced. The hsCRP, TNF- α levels and WBC 
counts reduced by 18, 2, and 14%, respectively [Table 2].
DISCUSSION
The present study was conducted with the purpose of 
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subjects with coronary artery disease. The study clearly 
showed that there was a significant reduction in the levels 
of serum inflammatory markers (hsCRP and WBC counts) 
after periodontal therapy. The study is in agreement with 
the results of previous studies[6-10] that stated a reduction in 
systemic inflammatory markers of inflammation associated 
with periodontitis post treatment.
In this study, non surgical therapy alone produced significant 
improvements in various periodontal parameters. BOP is an 
informative parameter to estimate the severity of gingival 
inflammation as well as the response to treatment, and it is 
a clinical indicator of disease progression and stability[11]. 
BOP ≤ 20% of sites is associated with a lower risk for 
periodontal attachment loss. In the present study, BOP 
was significantly reduced 1 month after treatment, and the 
number of subjects with BOP >20% of sites at baseline was 
reduced by almost half after therapy. Similarly, all subjects 
experienced significant reductions in PD after the treatment.
In this study, 1month after mechanical therapy, the 
circulating levels of hsCRP and WBC counts significantly 
reduced in all subjects. CRP is a prognostic marker for 
future cardiovascular events.[12] The release of bacteria and 
proinflammatory mediators such as bacterial endotoxins 
and cytokines in the bloodstream that causes the release of 
acute phase reactants (such as C reactive protein) leading to 
increased inflammatory activity in atherosclerotic lesions may 
represent the link between periodontal infection and CAD.
In addition, subjects with periodontitis present with 
higher counts of WBCs. WBC count, a crude marker of 
systemic inflammation associated with the prediction of 
future cardiovascular events[13] also significantly decreased 
for subjects with CAD. Individuals in our study showed a 
significant reduction of WBC after 1 month.
TNF-α has a role in apoptosis, bone resorption, matrix 
metalloproteinase (MMP) and IL- 6 production. It has also 
been associated with increased risk of recurrent coronary 
events[14]. However, the role of TNF - α remains disputed as 
several studies have not been able to recognize its association 
to cardiovascular events.[15] Also, in our study there was no 
significant reduction in the levels of TNF- α. Large sample 
size is required to justify the association of TNF-α.
The observation that cardiovascular risk factors might 
be influenced by periodontitis may have important 
clinical consequences. First, as inflammation plays 
an important role in the pathophysiology of various 
conditions (metabolic syndrome, BP, vascular health).[16]
The association of mild chronic inflammation with future 
serious events in observational studies[17] may be influenced 
by an underlying severe periodontal infection. Second, 
periodontitis may increase the risk of future cardiovascular 
events because of the pro atherogenic changes (increased 
cholesterol) and increased systolic blood pressure induced 
in affected individuals. Cigarette smoking represents the 
major influential factor with regard to the association 
between periodontal infections and systemic inflammation, 
and this preliminary investigation raises the hypothesis of 
a possible interaction of smoking, periodontal infection 
and systolic blood pressure on systemic health.Third, if 
periodontitis were the major inflammatory stimulus in at 
least some patients with periodontitis, severe periodontal 
infections may represent a major etiologic factor for 
atherosclerosis, metabolic syndrome, and their sequelae.
Still, the causal relationship between periodontitis and CAD 
cannot be established as the sample size was small and the 
role of other risk factors was not explored. On the basis of 
the data obtained, a large scale interventional study could 
be conducted in future.
CONCLUSION
•	 Poor oral health is detrimental to systemic health.
•	 Inflammatory markers are significantly associated with 
periodontitis.
•	 Periodontitis is a modifiable risk factor, which can be 
prevented and treated.
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